Kangstem Biotech Decides on 50 Billion KRW Rights Offering to Shareholders

[Asia Economy Reporter Yoo Byung-don] Kangstem Biotech announced on the 2nd that it has decided to conduct a rights offering followed by a general public offering of forfeited shares to raise approximately 50 billion KRW for operating funds and other purposes.

New shares totaling 12,376,237 common shares will be issued at 4,040 KRW per share.